Oramed Pharmaceuticals
ORMP
#9078
Rank
NZ$0.29 B
Marketcap
NZ$7.19
Share price
3.48%
Change (1 day)
88.64%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of NZ$0.13 Billion, an increase over its 2024 earnings that were of -NZ$26.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B0.1%
2025 NZ$0.13 B-616.9%
2024 -NZ$26.03 Million-311.47%
2023 NZ$12.3 M-119.45%
2022 -NZ$63.28 Million39.17%
2021 -NZ$45.47 Million73.93%
2020 -NZ$26.15 Million18.53%
2019 -NZ$22.06 Million-16.62%
2018 -NZ$26.46 Million38.32%
2017 -NZ$19.13 Million12.51%
2016 -NZ$17 Million25.01%
2015 -NZ$13.6 Million18.18%
2014 -NZ$11.51 Million39.72%
2013 -NZ$8.24 Million46.4%
2012 -NZ$5.63 Million128.32%
2011 -NZ$2.47 Million-51.47%
2010 -NZ$5.08 Million35.21%
2009 -NZ$3.76 Million
2007 -NZ$5.91 Million607.04%
2006 -NZ$0.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$43.21 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$13.23 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.93 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$45.08 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ$60.26 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel